Type 2 diabetes goes into remission for some patients as blood sugar control improves dramatically
Scripts of the 0.25mg starter dose are -37% w/w and it is known Novo restricts this supply to constrain new patient starts, perhaps implying current supply bottlenecks, just at the time competitor Lilly has removed the shortages of Mounjaro/Zepbound. Next Wave of GLP-1s So much attention in the GLP-1 space is on the Lilly-Novo duopoly, which is expected to retain around 70% of a potential $200 billion total market, according to a report last month from PitchBook and Morningstar
Astrup, A, Carraro, R, Finer, N, et al
A prescription for a compounded version is no longer an automatic substitute for an FDA-approved brand-name medication
Hin nay c rt nhiu phng php lm trng da cp tc nhng hiu qu mang li ch trong thi gian ngn, thm ch da b mng yu v kh nng bo mn mnh
When we run a peptide production batch, we produce all vial strengths (MG sizes) in the same run using the same raw material, lyophilization cycle, and fill/finish process
